Li Xu, Guo Xiaolin, Ji Huifan, Yu Ge, Gao Pujun
Department of Hepatology, The First Hospital of Jilin University, Jilin University, Changchun, China.
Biomed Res Int. 2017;2017:9749802. doi: 10.1155/2017/9749802. Epub 2017 Jan 31.
With prevalence of 10-20% in adults in developed countries, gallstone disease (GSD) is one of the most prevalent and costly gastrointestinal tract disorders in the world. In addition to gallstone disease, chronic liver disease (CLD) is also an important global public health problem. The reported frequency of gallstone in chronic liver disease tends to be higher. The prevalence of gallstone disease might be related to age, gender, etiology, and severity of liver disease in patients with chronic liver disease. In this review, the aim was to identify the epidemiology, mechanisms, and treatment strategies of gallstone disease in chronic liver disease patients.
在发达国家,胆结石病(GSD)在成年人中的患病率为10%-20%,是全球最常见且成本高昂的胃肠道疾病之一。除胆结石病外,慢性肝病(CLD)也是一个重要的全球公共卫生问题。慢性肝病患者中胆结石的报告发病率往往更高。胆结石病的患病率可能与慢性肝病患者的年龄、性别、病因及肝病严重程度有关。在本综述中,目的是确定慢性肝病患者胆结石病的流行病学、发病机制及治疗策略。